Working together to develop plans for a coordinated One Health response to antimicrobial resistance in Canada
Antimicrobials, used to treat infections in humans and animals, are losing their effectiveness — and the implications are stark. Like other countries, Canada must take immediate action to slow the rising trend of antimicrobial resistance (AMR). However, due to the complexity of the response required and the vast number of actors involved, the issue currently falls outside the jurisdiction of any existing oversight body. That’s why, through broad consultation, we’re developing model options for a network that will take on that responsibility. Funded by the Public Health Agency of Canada, this time-limited project will work with Canadian stakeholders to ensure a diversity of voices as we design and refine network model options and present recommendations for implementation. The models that we ultimately recommend will support the implementation of the forthcoming Pan-Canadian Action Plan while also coordinating broader efforts with respect to AMR and antimicrobial use (AMU). In order to do this all effectively, though, we need your help.
DOCUMENTS & REPORTS
We are delighted to have published the final report of our project, Strengthening Governance of the Antimicrobial Resistance Response Across One Health in Canada. With the submission of the report to the Public Health Agency of Canada, our project is complete.
While we have had the honour of leading this work, the ideas and insights contained in the report reflect the contributions of hundreds of people within the AMR community, from across One Health. Your commitment to solving the AMR problem in Canada has been inspiring.
We have done our best to transmit a sense of urgency in Canada moving forward to implement one of the proposed models. As noted at the end of our report, “we are eager and optimistic as we await the next steps.”
The Public Health Agency of Canada (PHAC) has funded our one-year endeavour to design model options for a network capable of sustainably and effectively addressing coordination gaps in Canada’s AMR response. We are in the process of consulting with interested parties across all sectors and levels of government that have a mandate, focus, or interest in areas related to AMR. These broad consultations will become the framework for governance model options and recommendations, which we expect to deliver by March 2021.
As defined by the US One Health Commission, "One Health is a collaborative, multisectoral, and trans-disciplinary approach — working at local, regional, national, and global levels — to achieve optimal health and well-being outcomes by recognizing the interconnections between people, animals, plants, and their shared environment."
We are collaborating with people from coast to coast to coast to inform and strengthen our network model options. Together, we are taking a national, multi-sector, multi-disciplinary approach to creating model options for AMR coordination in Canada. Project leadership is composed of representatives from across the One Health spectrum. Together, they are guiding the broad consultations that will ultimately shape our recommendations. While this team is steering our project plans, it is our large community of stakeholders — who represent organizations across the country that are engaged in either human, animal, or environmental health initiatives — that will determine the outcome. Leveraging Canada’s immense AMR expertise, we are building models for a network that will be representative, inclusive, equitable, comprehensive, evidence-informed, and action-oriented.
We surveyed hundreds of Canadian AMR stakeholders to help us understand the current landscape in Canada. We asked participants about their current AMR-related activities, the organizations they represent, what value they would get from a network, where in Canada they're based, who they collaborate with, and much more.
NEWS & LITERATURE
Series 1 Town Hall:
Summary of Findings
October 20, 2020 | Project: AMR Network
Throughout August and September of 2020, we consulted with Canada's broader AMR community over Zoom about eight potential network functions. This report summarizes the input, observations, advice, and concerns of 150 stakeholders from across Canada.
Legacy of COVID-19
April 1, 2020 | The Globe and Mail
The widespread, inadvertent use of antimicrobial drugs in this pandemic could leave us with another, more dangerous legacy: a dramatic increase in drug-resistant infections. Drug-resistant infections emerge through a complex interplay of humans, animals and the environment.
When Antibiotics Fail
November 12, 2019 | CCA
"When Antibiotics Fail" examines
the current impacts of antimicrobial resistance on the Canadian healthcare system, projects the future impact on Canada’s GDP, and looks at how widespread antibiotic resistance will influence the day-to-day lives of Canadians.